Oak Asset Management LLC lessened its holdings in UnitedHealth Group Inc (NYSE:UNH) by 2.5% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,322 shares of the healthcare conglomerate’s stock after selling 137 shares during the quarter. Oak Asset Management LLC’s holdings in UnitedHealth Group were worth $1,359,000 at the end of the most recent reporting period.
Other institutional investors have also recently added to or reduced their stakes in the company. Canton Hathaway LLC bought a new position in UnitedHealth Group during the 1st quarter worth approximately $36,000. Truvestments Capital LLC bought a new position in UnitedHealth Group during the 1st quarter worth approximately $42,000. Creative Financial Designs Inc. ADV raised its holdings in UnitedHealth Group by 89.6% during the 1st quarter. Creative Financial Designs Inc. ADV now owns 201 shares of the healthcare conglomerate’s stock worth $50,000 after purchasing an additional 95 shares during the last quarter. Financial Gravity Wealth Inc. bought a new position in UnitedHealth Group during the 1st quarter worth approximately $58,000. Finally, Horan Capital Advisors LLC. bought a new position in UnitedHealth Group during the 1st quarter worth approximately $68,000. Hedge funds and other institutional investors own 85.87% of the company’s stock.
NYSE UNH traded up $0.19 during mid-day trading on Tuesday, hitting $245.25. The company’s stock had a trading volume of 1,461,631 shares, compared to its average volume of 3,766,270. The firm’s 50 day moving average price is $251.75. UnitedHealth Group Inc has a twelve month low of $208.07 and a twelve month high of $287.94. The company has a quick ratio of 0.73, a current ratio of 0.67 and a debt-to-equity ratio of 0.62. The stock has a market capitalization of $237.63 billion, a price-to-earnings ratio of 19.04, a price-to-earnings-growth ratio of 1.33 and a beta of 0.61.
Several research analysts have issued reports on the stock. Zacks Investment Research upgraded shares of UnitedHealth Group from a “sell” rating to a “buy” rating and set a $269.00 price target for the company in a report on Monday, July 22nd. Oppenheimer set a $312.00 price objective on shares of UnitedHealth Group and gave the company a “buy” rating in a research note on Friday, July 19th. Barclays lowered their price objective on shares of UnitedHealth Group from $290.00 to $270.00 and set an “overweight” rating for the company in a research note on Wednesday, April 17th. Raymond James lifted their price objective on shares of UnitedHealth Group from $265.00 to $300.00 and gave the company a “buy” rating in a research note on Friday, July 19th. Finally, Royal Bank of Canada set a $311.00 price objective on shares of UnitedHealth Group and gave the company a “buy” rating in a research note on Friday, July 19th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and eighteen have given a buy rating to the stock. UnitedHealth Group has a consensus rating of “Buy” and a consensus price target of $295.06.
In other UnitedHealth Group news, Director Richard T. Burke sold 10,000 shares of UnitedHealth Group stock in a transaction on Wednesday, May 29th. The shares were sold at an average price of $241.99, for a total transaction of $2,419,900.00. Following the transaction, the director now directly owns 187,663 shares of the company’s stock, valued at approximately $45,412,569.37. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director William C. Ballard, Jr. sold 12,000 shares of UnitedHealth Group stock in a transaction on Tuesday, July 23rd. The stock was sold at an average price of $255.31, for a total transaction of $3,063,720.00. Following the transaction, the director now directly owns 61,309 shares in the company, valued at $15,652,800.79. The disclosure for this sale can be found here. In the last three months, insiders sold 32,000 shares of company stock valued at $7,963,620. 0.82% of the stock is currently owned by insiders.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Read More: Marijuana Stocks
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.